Lactobacillus rhamnosus GG supernatant enhance neonatal resistance to systemic Escherichia coli K1 infection by accelerating development of intestinal defense

Scientific Reports

Volumn 7, Issue , 2017, Pages

  He, Xiaolong ^a   Zeng, Qing ^a   Puthiyakunnon, Santhosh ^a   Zeng, Zhijie ^a   Yang, Weijun ^a   Qiu, Jiawen ^a   Du, Lei ^a   Boddu, Swapna ^a   Wu, Tongwei ^a   Cai, Danxian ^a   Huang, Sheng He ^a,b   Cao, Hong ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL ANTIGEN; BACTERIAL POLYSACCHARIDE; CAPSULAR POLYSACCHARIDE K1;

ANIMAL; BACTERIAL TRANSLOCATION; BACTERIUM ADHERENCE; CACO-2 CELL LINE; DISEASE MODEL; DISEASE RESISTANCE; DRUG EFFECT; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GASTROINTESTINAL TRACT; HUMAN; IMMUNOLOGY; LACTOBACILLUS RHAMNOSUS; METABOLISM; NEWBORN; NEWBORN SEPSIS; PHYSIOLOGY; RAT;

ANIMALS; ANIMALS, NEWBORN; ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; BACTERIAL ADHESION; BACTERIAL TRANSLOCATION; CACO-2 CELLS; DISEASE MODELS, ANIMAL; DISEASE RESISTANCE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GASTROINTESTINAL TRACT; HUMANS; LACTOBACILLUS RHAMNOSUS; NEONATAL SEPSIS; POLYSACCHARIDES, BACTERIAL; RATS;

EID: 85014779829     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep43305     Document Type: Article

References (63)

1. Stoll, B. J., et al. Trends in Care Practices, Morbidity, Mortality of Extremely Preterm Neonates, 1993-2012. Journal of the American Medical Association 314, 1039-1051 (2015).
2. Furyk, J. S., Swann, O., Molyneux, E. Systematic review: neonatal meningitis in the developing world. Tropical Medicine & International Health Tm & Ih 16, 672-679 (2011).
3. Brouwer, M. C., Tunkel, A. R., Van, d. B. D. Epidemiology, diagnosis, antimicrobial treatment of acute bacterial meningitis. Clinical Microbiology Reviews 23, 467-492 (2010).
4. Leib, S. L., Taüber, M. G. Pathogenesis of bacterial meningitis. Infectious Disease Clinics of North America 13, 527-548 (1999).
5. Kim, K. S. Current concepts on the pathogenesis of Escherichia coli meningitis: implications for therapy and prevention. Current Opinion in Infectious Diseases 25, 273-278 (2012).
6. Cornette, L. Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. Journal of Pediatrics 159, 720-725 (2011).
7. Kim, K. S. Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury. Nature Reviews Neuroscience 4, 376-385 (2003).
8. Witcomb, L. A., Collins, J. W., Mccarthy, A. J., Frankel, G., Taylor, P. W. Bioluminescent Imaging Reveals Novel Patterns of Colonization and Invasion in Systemic Escherichia coli K1 Experimental Infection in the Neonatal Rat. Infection & Immunity 83, 4528-4540 (2015).
9. Yousuf, F. A., et al. Interactions of neuropathogenic Escherichia coli K1 (RS218) and its derivatives lacking genomic islands with phagocytic Acanthamoeba castellanii and nonphagocytic brain endothelial cells. Biomed Research International 2014, 265424-265424 (2014).
10. Wang, S., et al. Pathogenic Triad in Bacterial Meningitis: Pathogen Invasion, NF- B Activation, Leukocyte Transmigration that Occur at the Blood-Brain Barrier. Frontiers in Microbiology 7, 10. 3389/fmicb. 2016. 00148 (2016).
11. Huang, S. H., He, L., Zhou, Y., Wu, C. H., Jong, A. Lactobacillus rhamnosus GG Suppresses Meningitic E. coli K1 Penetration across Human Intestinal Epithelial Cells In Vitro and Protects Neonatal Rats against Experimental Hematogenous Meningitis. International Journal of Microbiology 2009, 10. 1155/2009/647862 (2009).
12. Hotel, A. C. P. Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria-Joint FAO/WHO Expert Consultation. 2014 (2001).
13. Delzenne, N. M., Neyrinck, A. M., Bäckhed, F., Cani, P. D. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nature Reviews Endocrinology 4, 639-646 (2011).
14. Harb, H., et al. Neonatal supplementation of processed supernatant from Lactobacillus rhamnosus GG improves allergic airway inflammation in mice later in life. Clinical & Experimental Allergy 43, 353-364 (2013).
15. Jakaitis, B. M., Denning, P. W. Commensal and probiotic bacteria may prevent NEC by maturing intestinal host defenses. Pathophysiology 21, 47-54 (2014).
16. Yang, X., et al. High protective efficacy of rice bran against human rotavirus diarrhea via enhancing probiotic growth, gut barrier function, innate immunity. Scientific Reports 5, 10. 1038/srep15004 (2015).
17. Khailova, L., Frank, D. N., Dominguez, J. A., Wischmeyer, P. E. Probiotic administration reduces mortality and improves intestinal epithelial homeostasis in experimental sepsis. Anesthesiology 119, 166-177 (2013).
18. Khailova, L., Petrie, B., Baird, C. H., Dominguez Rieg, J. A., Wischmeyer, P. E. Lactobacillus rhamnosus GG and Bifidobacterium longum attenuate lung injury and inflammatory response in experimental sepsis. Plos One 9, e97861 (2014).
19. Saini, R., Saini, S., Sharma, S. Potential of probiotics in controlling cardiovascular diseases. Journal of Cardiovascular Disease Research 1, 213-214 (2010).
20. Howarth, G. S., Wang, H. Role of endogenous microbiota, probiotics and their biological products in human health. Nutrients 5, 58-81 (2013).
21. Howarth, G. S. Probiotic-derived factors: probiotaceuticals Journal of Nutrition 140, 229-230 (2010).
22. Robin, F., et al. Lactobacillus rhamnosus meningitis following recurrent episodes of bacteremia in a child undergoing allogeneic hematopoietic stem cell transplantation. Journal of Clinical Microbiology 48, 4317-4319 (2010).
23. Kulkarni, H. S., Khoury, C. C. Sepsis associated with Lactobacillus bacteremia in a patient with ischemic colitis. Indian journal of critical care medicine: peer-reviewed, official publication of Indian Society of Critical Care Medicine 18, 606-608 (2014).
24. Gouriet, F., Million, M., Henri, M., Fournier, P. E., Raoult, D. Lactobacillus rhamnosus bacteremia: an emerging clinical entity. European Journal of Clinical Microbiology & Infectious Diseases 31, 2469-2480 (2012).
25. Besselink, M. G., et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371, 651-659 (2008).
26. Nougayrède, J. P., et al. Escherichia coli Induces DNA Double-Strand Breaks in Eukaryotic Cells. Science 313, 848-851 (2006).
27. Cuevas-Ramos, G., Isberg, R. R. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America 107, 11537-11542 (2010).
28. Million, M., Raoult, D. Publication biases in probiotics. European Journal of Epidemiology 27, 885-886 (2012).
29. Tsilingiri, K., et al. Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model. Gut 61, 1007-1015 (2012).
30. Tsilingiri, K., Rescigno, M. Postbiotics: what else Beneficial microbes 4, 101-107 (2012).
31. Patel, R. M., Denning, P. W. Therapeutic use of prebiotics, probiotics, postbiotics to prevent necrotizing enterocolitis: what is the current evidence Clinics in perinatology 40, 11-25 (2013).
32. Cicenia, A., et al. Postbiotic activities of lactobacilli-derived factors. Journal of clinical gastroenterology 48, S18-S22 (2014).
33. Fong, F. L. Y., Kirjavainen, P. V., Elnezami, H. Immunomodulation of Lactobacillus rhamnosus GG (LGG)-derived soluble factors on antigen-presenting cells of healthy blood donors. Scientific Reports 6, 10. 1038/srep22845 (2016).
34. Valeri, M., et al. Pathogenic E. coli Exploits SslE Mucinase Activity to Translocate through the Mucosal Barrier and Get Access to Host Cells. Plos One 10, 10. 1371/journal. pone. 0117486 (2015).
35. Wang, Y., et al. Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury. Ajp Gastrointestinal & Liver Physiology 303, 32-41 (2012).
36. Yoda, K., et al. Lactobacillus GG-fermented milk prevents DSS-induced colitis and regulates intestinal epithelial homeostasis through activation of epidermal growth factor receptor. European Journal of Nutrition 53, 105-115 (2014).
37. Seth, A., Yan, F., Polk, D. B., Rao, R. K. Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC-and MAP kinase-dependent mechanism. Ajp Gastrointestinal & Liver Physiology 294, G1060-1069 (2008).
38. Chen, R. C., et al. Lactobacillus rhamnosus GG supernatant promotes intestinal barrier function, balances T reg and T H 17 cells and ameliorates hepatic injury in a mouse model of chronic-binge alcohol feeding. Toxicology Letters 241, 103-110 (2015).
39. Zhang, M., et al. Enhanced AMPK phosphorylation contributes to the beneficial effects of Lactobacillus rhamnosus GG supernatant on chronic alcohol-induced fatty liver disease. Journal of Nutritional Biochemistry 26, 337-344 (2014).
40. Birchenough, G. M., et al. Altered Innate Defenses in the Neonatal Gastrointestinal Tract in Response to Colonization by Neuropathogenic Escherichia coli. Infection & Immunity 81, 3264-3275 (2013).
41. Moal, V. L., Servin, A. L. Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents. Clinical Microbiology Reviews 27, 167-199 (2014).
42. Derrien, M., Belzer, C., Vos, W. M. D. Akkermansia muciniphila and its role in regulating host functions. Microbial Pathogenesis 2016, 10. 1016/j. micpath. 2016. 02. 005 (2016).
43. Xavier, R. J., Podolsky, D. K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427-434 (2007).
44. Patel, R. M., et al. Probiotic Bacteria Induce Maturation of Intestinal Claudin 3 Expression and Barrier Function. American Journal of Pathology 180, 626-635 (2012).
45. Clayburgh, D. R., Shen, L., Turner, J. R. A porous defense: the leaky epithelial barrier in intestinal disease. Laboratory investigation; a journal of technical methods and pathology 84, 282-291 (2004).
46. Johnsonhenry, K. C., Donato, K. A., Shentu, G., Gordanpour, M., Sherman, P. M. Lactobacillus rhamnosus Strain GG Prevents Enterohemorrhagic Escherichia coli O157:H7-Induced Changes in Epithelial Barrier Function. Infection & Immunity 76, 1340-1348 (2008).
47. Piena-Spoel, M., Albers, M. J. I. J., Kate, J. T., Tibboel, D. Intestinal permeability in newborns with necrotizing enterocolitis and controls: Does the sugar absorption test provide guidelines for the time to (re-)introduce enteral nutrition . Journal of Pediatric Surgery 36, 587-592 (2001).
48. Holt, D. E., Halket, S., Louvois, J. D., Harvey, D. Neonatal meningitis in England and Wales: 10 years on. Archives of Disease in Childhood Fetal & Neonatal Edition 84, 85-89 (2001).
49. Hahn, H. P., et al. Intestinal differentiation in metaplastic, non-goblet columnar epithelium in the esophagus. American Journal of Surgical Pathology 33, 1006-1015 (2009).
50. Yan, F., et al. Neonatal colonization of mice with LGG promotes intestinal development and decreases susceptibility to colitis in adulthood. Mucosal Immunology 2016, 10. 1038/mi. 2016. 43. (2016).
51. Weng, M., Ganguli, K., Zhu, W., Shi, H. N., Walker, W. A. Conditioned medium from Bifidobacteria infantis protects against Cronobacter sakazakii-induced intestinal inflammation in newborn mice. American Journal of Physiology Gastrointestinal & Liver Physiology 306, 779-787 (2014).
52. Deshmukh, H. S., et al. The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice. Nature Medicine 20, 141-151 (2014).
53. Gutzeit, C., Magri, G., Cerutti, A. Intestinal IgA production and its role in host-microbe interaction. Immunological Reviews 260, 76-85 (2014).
54. Fransen, F., et al. BALB/c and C57BL/6 Mice Differ in Polyreactive IgA Abundance, which Impacts the Generation of Antigen-Specific IgA and Microbiota Diversity. Immunity 43, 527-540 (2015).
55. Macpherson, A. J., Mccoy, K. D., Johansen, F. E., Brandtzaeg, P. The immune geography of IgA induction and function. Mucosal Immunology 1, 11-22 (2008).
56. Yan, F., Polk, D. B. Lactobacillus rhamnosus GG: An Updated Strategy to Use Microbial Products to Promote Health. Functional Food Reviews 4, 77-84 (2012).
57. Wang, Y., et al. An LGG-derived protein promotes IgA production through upregulation of APRIL expression in intestinal epithelial cells. Mucosal Immunology. 7, 10. 1038/mi. 2016. 57 (2016).
58. Wang, L., et al. Activation of epidermal growth factor receptor mediates mucin production stimulated by p40, a Lactobacillus rhamnosus GG-derived protein. Journal of Biological Chemistry 289, 20234-20244 (2014).
59. Yu, J. Y., et al. Mucin2 is required for probiotic agents-mediated blocking effects on meningitic E. coli-induced pathogenicities. Journal of Microbiology & Biotechnology 25, 10. 4014/jmb. 1502. 02010 (2015).
60. Yu, J. Y., et al. Repositioning of Memantine as a Potential Novel Therapeutic Agent against Meningitic E. coli-Induced Pathogenicities through Disease-Associated Alpha7 Cholinergic Pathway and RNA Sequencing-Based Transcriptome Analysis of Host Inflammatory Responses. Plos One 10, 10. 1371/journal. pone. 0121911 (2015).
61. Dalgakiran, F., Witcomb, L. A., Mccarthy, A. J., Birchenough, G. M., Taylor, P. W. Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat. Journal of Visualized Experiments Jove 92, e52018-e52018 (2014).
62. Wang, H., et al. Pro-inflammatory miR-223 mediates the cross-talk between the IL23 pathway and the intestinal barrier in inflammatory bowel disease. Genome Biology 17, 1-15 (2016).
63. Reid, W. C., et al. Characterization of neuropathology in the HIV-1 transgenic rat at different ages. Journal of Neuroimmunology 292, 116-125 (2016)